Assessment of Public Opinion on Transparency at the US Food and Drug Administration

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products2019 · 41 citations
2. 2Enhancing Transparency at the US Food and Drug Administration2017 · 17 citations
3. 3Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered2021 · 43 citations
4. 4Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust2020 · 82 citations
5. 5Blueprint for Transparency at the U.S. Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products2017 · 30 citations